Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism

被引:24
作者
Kovacevic, Bojan [1 ]
Ignjatovic, Mile [1 ]
Zivaljevic, Vladan [2 ]
Cuk, Vladimir [1 ]
Scepanovic, Milena [1 ]
Petrovic, Zaklina [1 ]
Paunovic, Ivan [2 ]
机构
[1] KBC Zvezdara Univ, Ctr Clin, Clin Surg Nikola Spasic, Belgrade 11000, Serbia
[2] Clin Ctr Serbia, Ctr Endocrine Surg, Inst Endocrinol Diabet & Dis Metab, Belgrade 11000, Serbia
关键词
Secondary hyperparathyroidism; NKF-K/DOQI; KDIGO; Parathyroidectomy; Calcimimetics; MORTALITY RISK; MEDICAL THERAPY; BLOOD-PRESSURE; TARGET VALUES; SERUM-CALCIUM; HEMODIALYSIS; CINACALCET; ASSOCIATION; OUTCOMES; HORMONE;
D O I
10.1007/s00423-011-0901-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI (TM)) 2003 and Kidney Disease: Improving Global Outcomes (KDIGO) 2009 have established guidelines for the treatement of secondary hyperparathyroidism. This study evaluated the impact of parathyroidectomy to achieve recommended values for parathyroid hormone, calcium, phosphorus and CaxPO(4) product in dialysis patients with severe secondary hyperparathyroidism that is resistant to medical treatment. This study included 43 consecutive patients who underwent parathyroidectomy for a severe form of secondary hyperparathyroidism (SHPT) that is unresponsive to medical treatment. The serum iPTH, calcium and phosphorus levels were measured prior to surgery, every morning after surgery for 5 days and on the first, sixth and eighth postoperative months. Following parathyroidectomy, a significant decline in iPTH values was observed in all patients; however, after the 8-month study period, only one of these patients achieved a serum iPTH concentration within the K/DOQI recommended target range. Unlike iPTH, targeting for calcium, phosphorus and CaxPO(4) at the last follow-up were 55.8%, 60.5% and 93%, respectively. These values indicated a significant improvement in comparison to preoperative percentages. In regards to the KDIGO recommended guidelines, the iPTH levels did not significantly change at the end of our study compared to preoperative values; however, calcium levels significantly declined and phosphorus levels significantly improved compared to preoperative values. Although the majority of patients fail to reach recommended iPTH values, parathyroidectomy remains a valuable tool to attain these NKF-K/DOQI recommendations for serum calcium, phosphorus and CaxPO(4) in dialysis patients with secondary hyperparathyroidism resistant to medical therapy. Parathyroidectomy was shown to be an inadequate intervention for achieving KDIGO recommendations.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 26 条
[11]  
Gal-Moscovici A, 2005, CLIN NEPHROL, V63, P284
[12]  
Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131
[13]   Ambulatory blood pressure monitoring in renal dialysis and transplant patients [J].
Goldsmith, DJA ;
Covic, AC ;
Venning, MC ;
Ackrill, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) :593-600
[14]   Survival following parathyroidectomy among United States dialysis patients [J].
Kestenbaum, B ;
Andress, DL ;
Schwartz, SM ;
Gillen, DL ;
Seliger, SL ;
Jadav, PR ;
Sherrard, DJ ;
Stehman-Breen, C .
KIDNEY INTERNATIONAL, 2004, 66 (05) :2010-2016
[15]   Foreword [J].
Eckardt, Kai-Uwe ;
Kasiske, Bertram L. .
KIDNEY INTERNATIONAL, 2009, 76 :S1-S2
[16]  
Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x
[17]   Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in Hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study [J].
Lindberg, JS ;
Culleton, B ;
Wong, G ;
Borah, MF ;
Clark, RV ;
Shapiro, WB ;
Roger, SD ;
Husserl, FE ;
Klassen, PS ;
Guo, MD ;
Albizem, MB ;
Coburn, JW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03) :800-807
[18]   Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI™ ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients [J].
Mazzaferro, Sandro ;
Pasquali, Marzia ;
Farcomeni, Alessio ;
Vestri, Anna Rita ;
Filippini, Angelo ;
Romani, Anna Maria ;
Barresi, Giusi ;
Pugliese, Francesco .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) :2319-2323
[19]   Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl [J].
Moe, SM ;
Chertow, GM ;
Coburn, JW ;
Quarles, LD ;
Goodman, WG ;
Block, GA ;
Drüeke, TB ;
Cunningham, J ;
Sherrard, DJ ;
McCary, LC ;
Olson, KA ;
Turner, SA ;
Martin, KJ .
KIDNEY INTERNATIONAL, 2005, 67 (02) :760-771
[20]   Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis [J].
Narayan, Rajeev ;
Perkins, Robert M. ;
Berbano, Elizabeth P. ;
Yuan, Christina M. ;
Neff, Robert T. ;
Sawyers, Eric S. ;
Yeo, Fred E. ;
Vidal-Trecan, Gwenaelle M. ;
Abbott, Kevin C. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (06) :801-813